A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

Tom Brady's dog is a clone of a "beloved" pet that died, the seven-time Super Bowl champion revealed on Tuesday.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older ...

Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...